openPR Logo
Press release

Surgical Site Infections Market Poised for Transformative Growth by 2034, Predicts DelveInsight

03-26-2025 12:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Surgical Site Infections Market

Surgical Site Infections Market

The Surgical Site Infections market is steadily advancing, driven by evolving treatment strategies and ongoing research. DelveInsight's latest 7MM report offers in-depth insights into key epidemiology trends and market dynamics.
DelveInsight's "Surgical Site Infections - Market Insight, Epidemiology, And Market Forecast - 2034 [https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr] report offers an in-depth understanding of the Surgical Site Infections, historical and forecasted epidemiology as well as the Surgical Site Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Some of the key facts of the Surgical Site Infections Market Report:

- According to DelveInsight, the market for Surgical Site Infections in the 7MM is expected to witness notable growth during the study period from 2020 to 2034.

- According to findings, cigarette smoking has a negative impact on wound healing in orthopedic surgery, with an increase in the incidence of surgical site infection of 7%.

- Research indicates that surgical site infections occur in 2% to 4% of all patients undergoing inpatient surgical procedures.

- The overall incidence of surgical site infections was around 10% in the early 2000s, gradually decreasing to 7% by 2007 and further dropping to 5% by 2020.

- In March 2025, PolyPid Ltd. announced the successful completion of enrollment in the SHIELD II Phase 3 trial for D-PLEX100, aimed at preventing surgical site infections in patients undergoing abdominal colorectal surgery.

- In August 2024, Guard Medical Inc. announced FDA 510(k) clearance for larger sizes of its NPseal Negative Pressure Wound Therapy (NPWT) dressing, now available for surgical wounds up to 25cm. NPseal is a user-friendly, affordable dressing with an integrated pump that quickly establishes and maintains negative pressure.

- Emerging therapies in the Surgical Site Infections Treatment Market focus on innovations like PolyPid's D-PLEX100 for localized antibiotic delivery and Destiny Pharma's XF-73 antimicrobial peptides, aiming to reduce infections and fight antibiotic resistance.

- Leading companies in the Surgical Site Infections market include Destiny Pharma, PolyPid, Menarini Group Pharma, Botanix Pharma, Dr. Reddy's Laboratories Ltd., Zurex Pharma, and others.

- The rising number of radiation therapy patients and advancements in therapeutic options continue to drive the demand for effective Surgical Site Infections treatments.

To know in detail about the Surgical Site Infections market outlook, drug uptake, treatment scenario, and epidemiology trends, click here: Surgical Site Infections Market Forecast [https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Surgical Site Infections Overview

A surgical site infection (SSI) is an infection that develops at or near the incision site following a surgical procedure, potentially affecting different tissue layers. Common symptoms include redness, swelling, pain, fever, and the discharge of cloudy or purulent fluid. SSIs typically emerge within 30 days post-surgery and are categorized by the Centers for Disease Control and Prevention (CDC) into three types:

Superficial Incisional SSI: Affects the skin and subcutaneous tissue at the incision site.

Deep Incisional SSI: Involves deeper layers such as muscles and surrounding tissues.

Organ or Space SSI: Occurs in internal organs or spaces manipulated during surgery.

Diagnosis relies on clinical evaluation, wound cultures to identify infectious agents, and imaging techniques if deeper infections are suspected. Prompt identification and treatment are essential to managing SSIs and preventing complications.

Get a Free sample for the Surgical Site Infections Market Report:https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market [https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Surgical Site Infections Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Surgical Site Infections Epidemiology Segmentation:

The Surgical Site Infections epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by:

- Total Incident Cases of Surgical Site Infections

- Type-specific Cases of Surgical Site Infections,

- Organ-specific Cases of Surgical Site Infections

- Treated Cases of Surgical Site Infections

Download the report to understand which factors are driving Surgical Site Infections epidemiology trends @ Surgical Site Infections Epidemiology Forecast [https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Surgical Site Infections Drugs Uptake, and Pipeline Development Activities

The drug uptake section focuses on the rate of uptake of the potential drugs recently launched in the Surgical Site Infections market or expected to be launched during the study period. The analysis covers the Surgical Site Infections market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Surgical Site Infections Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Surgical Site Infections Market Strengths

- Increased awareness among healthcare professionals and patients, along with the implementation of stringent infection control protocols, has significantly contributed to reducing surgical site infections (SSIs). Advancements in antiseptic techniques, sterilization methods, and infection surveillance programs further strengthen the market.

- The development and adoption of novel antimicrobial-coated sutures, wound dressings, and advanced therapies such as negative pressure wound therapy (NPWT) have enhanced infection prevention and management, driving market growth.

Surgical Site Infections Market Weaknesses

- The implementation of advanced infection prevention strategies, including antimicrobial dressings, surveillance systems, and prophylactic antibiotic administration, can be costly, posing a challenge for healthcare facilities with limited budgets, especially in low- and middle-income countries.

- The growing concern over antimicrobial resistance (AMR) limits the effectiveness of traditional antibiotic therapies for SSIs, making treatment more challenging and increasing the need for novel antimicrobial strategies, which may take longer to develop and commercialize.

Scope of the Surgical Site Infections Market Report

- Study Period: 2020-2034

- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

- Key Surgical Site Infections Therapies: D-PLEX100, XF-73 Nasal gel, and others.

- Key Surgical Site Infections Companies: Destiny Pharma, PolyPid, Menarini Group Pharma, Botanix Pharma, Dr. Reddy's Laboratories Ltd., Zurex Pharma, and others.

- Surgical Site Infections Therapeutic Assessment: Surgical Site Infections currently marketed and Surgical Site Infections emerging therapies

- Surgical Site Infections Market Dynamics: Surgical Site Infections market drivers and Surgical Site Infections market barriers

- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

- Surgical Site Infections Unmet Needs, KOL's views, Analyst's views, Surgical Site Infections Market Access and Reimbursement

To learn more about the key players and advancements in the Surgical Site Infections Treatment Landscape, visit the Surgical Site Infections Market Analysis Report [https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Table of Contents

1. Surgical Site Infections Market Report Introduction

2. Executive Summary for Surgical Site Infections

3. SWOT analysis of Surgical Site Infections

4. Surgical Site Infections Patient Share (%) Overview at a Glance

5. Surgical Site Infections Market Overview at a Glance

6. Surgical Site Infections Disease Background and Overview

7. Surgical Site Infections Epidemiology and Patient Population

8. Country-Specific Patient Population of Surgical Site Infections

9. Surgical Site Infections Current Treatment and Medical Practices

10. Surgical Site Infections Unmet Needs

11. Surgical Site Infections Emerging Therapies

12. Surgical Site Infections Market Outlook

13. Country-Wise Surgical Site Infections Market Analysis (2020-2034)

14. Surgical Site Infections Market Access and Reimbursement of Therapies

15. Surgical Site Infections Market Drivers

16. Surgical Site Infections Market Barriers

17. Surgical Site Infections Appendix

18. Surgical Site Infections Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=surgical-site-infections-market-poised-for-transformative-growth-by-2034-predicts-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Surgical Site Infections Market Poised for Transformative Growth by 2034, Predicts DelveInsight here

News-ID: 3939383 • Views:

More Releases from ABNewswire

Lone Wolf Siding Emerges as the Best Siding Company in New Orleans Offering Premium Siding, Patios, and Pergolas
Lone Wolf Siding Emerges as the Best Siding Company in New Orleans Offering Prem …
Lone Wolf Siding is the best siding company in New Orleans, Louisiana. Image: https://www.abnewswire.com/upload/2025/09/3522ab792132a4d3ddba57316984a0de.jpg Lone Wolf Siding, a trusted siding contractor in New Orleans, proudly announces its expanded offerings designed to protect and enhance homes across Louisiana. With a strong foundation in expert siding installation and repair, the company now provides homeowners with a full suite of exterior solutions, including patios and pergolas, all backed by exceptional craftsmanship and a 100% satisfaction
Buerger's Disease Pipeline 2025: Pioneering Clinical Developments by 3+ Global Leaders - DelveInsight | Featuring Antidote Therapeutics, K-STEMCELL, Caladrius Biosciences
Buerger's Disease Pipeline 2025: Pioneering Clinical Developments by 3+ Global L …
DelveInsight's, "Buerger's Disease - Pipeline Insight, 2025," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Buerger's Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. As Buerger's Disease increasingly affects populations worldwide and is linked
Mucopolysaccharidosis III Pipeline 2025: Pioneering Clinical Progress by 8+ Global Leaders - DelveInsight | Featuring Ultragenyx Pharmaceutical Inc, JCR Pharmaceuticals Co., Ltd., GC Biopharma Corp, D
Mucopolysaccharidosis III Pipeline 2025: Pioneering Clinical Progress by 8+ Glob …
DelveInsight's, "Mucopolysaccharidosis III - Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Mucopolysaccharidosis III pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Mucopolysaccharidosis III (MPS III) is emerging as a significant global
Ovarian Cancer Clinical Trials, Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis
Ovarian Cancer Clinical Trials, Companies, Therapeutic Assessment, Emerging Ther …
Ovarian Cancer companies are Allarity Therapeutics, OSE Immunotherapeutic, Cristal Therapeutics, Bristol-Myers Squibb, Ono Pharmaceuticals, Merck & Co., Aravive Biologics, Mersana Therapeutics, Clovis Oncology, Verastem Oncology, Gradalis, AbbVie, Elevation oncology, OncoQuest Pharmaceuticals (CanariaBio), Alkermes, Hoffman-la Roche, AstraZeneca, MSD, GlaxoSmithKline, IMV, Corcept Therapeutics, and others. Ovarian Cancer Pipeline constitutes 180+ key companies continuously working towards developing 200+ Ovarian Cancer treatment therapies, analyzes DelveInsight. Ovarian Cancer Overview: Ovarian cancer is the deadliest gynecological cancer and the

All 5 Releases


More Releases for Surgical

Surgical Robotics Market to Witness Huge Growth by 2031 -Auris Surgical Robotics …
Surgical Robotics Industry Analysis, according DataM Intelligence. Although data provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future. Will the Surgical Robotics market emerge as the sector's next great thing? To discover the answer, look at the Surgical Robotics market analysis and projections. In-depth
Surgical Laser Market - Shaping Surgical Precision: Surgical Laser, Guiding the …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Surgical Laser Market. Surgical Laser Market: https://www.growthplusreports.com/report/surgical-laser-market/9172 The Surgical Laser Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.
Surgical Retractor Market - Enabling Surgical Mastery: Retractors for Uncompromi …
Newark, New Castle, USA: The "Surgical Retractor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Surgical Retractor Market: https://www.growthplusreports.com/report/surgical-retractor-market/7658 This latest report researches the industry structure, sales,
Surgical Robots Market Hits USD 17,647.82 million by 2028 Lead By THINK Surgical …
There is a rise in the number of surgeries performed across the world. In the last 25 years, the incidence of cardiovascular diseases has increased globally. The rise in diabetic cases and lifestyle changes are leading to an increase in the number of cardiovascular surgeries and general surgeries. For instance, colorectal cancer is one of the most commonly found and lethal cancers developed in individuals due to the combined influence
Surgical Robots Market Analysis 2020 - How COVID19 Impacting Surgical Robots Ind …
Report Analyzes Surgical Robots Market Size, Share and Industry Analysis By Type (Implantable Cardioverter Surgical Robots (ICD), Transvenous ICD, External Surgical Robots) By End User (Hospitals & Clinics, Ambulatory, Schools and other Public Places) and Regional Forecast, 2019 - 2026. Get Sample Report To Know The Impact of Covid19 on this Industry at: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/surgical-robots-market-100948 Key Players: Intuitive Surgical, Medtronic, Stryker, Smith & Nephew, Zimmer Biomet, TransEnterix Surgical, Inc Verb Surgical, THINK Surgical. An
Surgical Microscope Market Size, Surgical Microscope Market Share, Surgical Micr …
The global surgical microscope market was valued at USD 610.3 million in 2017 and is estimated to grow at a CAGR of 12.5% during the forecast period 2017-2026. Request for Sample of This Research Report @ https://bit.ly/2xjcXML Top Key Players:- Carl Zeiss AG, Leica Microsystems, Takagi Corporation, Seiler Precision Microscopes, Topcon Corporation, Alltion (Wuzhou) Co. Ltd., Alcon Laboratories, Inc., Haag-Streit Surgical, Olympus Corporation, Accu-scope, Inc., Novartis AG, Danaher Corporation, Labomed Microscopes, Prescott’s Inc.,